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A genome-wide screen identiﬁes YAP/WBP2
interplay conferring growth advantage on human
epidermal stem cells
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Individual human epidermal cells differ in their self-renewal ability. To uncover the molecular
basis for this heterogeneity, we performed genome-wide pooled RNA interference screens
and identiﬁed genes conferring a clonal growth advantage on normal and neoplastic
(cutaneous squamous cell carcinoma, cSCC) human epidermal cells. The Hippo effector YAP
was amongst the top positive growth regulators in both screens. By integrating the Hippo
network interactome with our data sets, we identify WW-binding protein 2 (WBP2) as an
important co-factor of YAP that enhances YAP/TEAD-mediated gene transcription. YAP and
WPB2 are upregulated in actively proliferating cells of mouse and human epidermis and
cSCC, and downregulated during terminal differentiation. WBP2 deletion in mouse skin
results in reduced proliferation in neonatal and wounded adult epidermis. In reconstituted
epidermis YAP/WBP2 activity is controlled by intercellular adhesion rather than canonical
Hippo signalling. We propose that defective intercellular adhesion contributes to uncontrolled
cSCC growth by preventing inhibition of YAP/WBP2.
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M
ammalian epidermis comprises a multi-layered
epithelium, the inter-follicular epidermis (IFE), which
forms the protective interface between the body and the
environment, and various epidermal appendages including hair
follicles, sebaceous glands and sweat glands1. Maintenance of the
IFE and its appendages depends on several distinct stem cell (SC)
populations2–4. IFE SCs reside in the basal cell layer of the
epithelium that is anchored to a basement membrane, and divide
to produce SCs that remain in the basal cell layer or cells that are
destined to undergo terminal differentiation in the suprabasal cell
layers (committed progenitor cells (CPs))1,5.
One of the characteristic tumours of the IFE is cutaneous
squamous cell carcinoma (cSCC). These tumours retain some
hallmarks of the normal epithelial terminal differentiation
programme; however, proliferation is increased, the proportion
of differentiated cells is decreased, and the spatial organization of
the cell layers is disrupted6,7. There is evidence that cSCCs are
maintained by a subpopulation of highly proliferative cells termed
cancer SCs8. These neoplastic SCs appear to hijack the
homeostatic controls that operate in normal SCs, eliminating
those that promote differentiation and upregulating those that
exert a positive effect on proliferation7.
Primary human epidermal cells and cSCC cells can readily be
grown in culture9,10. A subset of highy proliferative epidermal
cells has the potential to generate large stratiﬁed colonies that
subsequently fuse to form multi-layered cell sheets, recapitulating
the organization of the epidermis9,11–13. This culture system has
been widely used to study human epidermal SCs and their
regulation11–15, and epidermal sheets generated in vitro are used
for autologous transplantation in patients suffering from
severe burn wounds or hereditary skin blistering diseases16,17.
The grafted epidermal sheets can persist as a histologically
and physiologically normal epidermis for years16–18. However,
due to the marked heterogeneity in the proliferative potential
of individual primary human epidermal cells11–13 engraftment
of epidermal sheets after transplantation is highly
unpredictable18–20.
In this study, we used an unbiased approach to uncover the
molecular basis for this heterogeneity by performing genome-
wide pooled RNA interference (RNAi) screens in normal
epidermal cells and neoplastic (cSCC) cells with increased growth
potential. This led us to identify the Hippo effector YAP and its
co-factor WBP2 as drivers of clonal expansion of normal and
neoplastic human epidermal SCs via TEAD transcription factors.
By examining the functions of YAP and WBP2 and their
upstream regulators we provide new evidence for the role of
canonical and non-canonical Hippo signalling in normal and
neoplastic epidermis.
Results
Genome-wide RNAi screen. To identify genes that confer a
clonal growth advantage on primary human epidermal cells
(normal human keratinocytes; NHKs), we conducted a genome-
wide RNAi screen, using pooled short-hairpin RNAs (shRNAs)
(Fig. 1a,b). We screened 82,305 shRNAs targeting 15,256 protein-
coding genes (Fig. 1a,b and Supplementary Data 1), with each
gene being targeted by 5–6 individual shRNAs. The abundance of
each genome-integrated barcoded lentiviral hairpin was quanti-
ﬁed from genomic DNA by Illumina deep sequencing21 (Fig. 1c)
in the initial cell population (24 h after lentiviral transduction;
t¼ 0) and after 14 days of culture at a clonal seeding density on a
3T3-J2 ﬁbroblast feeder layer (t¼ 14), by which time the cells had
formed a conﬂuent, stratiﬁed sheet (Fig. 1a,b). Under these
culture conditions individual epidermal SCs initially give rise to
exponentially growing (expanding) colonies11 that eventually
become multi-layered as differentiating cells in the colony
stratify9,11,13, causing a switch in the growth behaviour in the
colony centre to a ‘balanced’ mode where similar proportions
of proliferating and differentiating cells are generated11
(Supplementary Movie 1). In contrast, CP cells (transit
amplifying cells) form abortive colonies with a very limited
growth capacity due to early onset of terminal differentiation12,13
(Supplementary Movie 2). Since the bulk growth of a NHK
population in culture is driven by the SC fraction11–13, the
majority of hits identiﬁed in the screen should represent genes
that promote clonal expansion of SCs (Fig. 1b) rather than genes
that directly regulate the onset of terminal differentiation. We
focused on shRNAs that were signiﬁcantly under-represented at
t¼ 14, since they should target genes that positively regulate SC
proliferation and survival or negatively regulate the transition
from SC to CP cell (Fig. 1b).
To complement the NHK screen we introduced the shRNA
library into SCC13 cells, a cell line established from a cSCC10 that
fails to undergo terminal differentiation in culture22. Compared
with NHKs, SCC13 cells have a much higher colony forming
efﬁciency22, consistent with an expansion of their SC pool. We
measured the abundance of each genome-integrated barcoded
lentiviral hairpin in SCC13 cells at t¼ 0 and after 14 days in
culture after plating at clonal density, by which time the cells
formed a conﬂuent, partially multi-layered cell sheet (Fig. 1a–c).
Gene target hits from both screens were identiﬁed
using a bioinformatics pipeline (see Supplementary Methods,
Supplementary Figs 1,2,3a,b, Supplementary Data 2). We
identiﬁed 641 and 6,109 candidate genes essential for NHK and
SCC13 clonal growth, respectively (Fig. 1d,e, Supplementary
Fig. 3c,d and Supplementary Data 3). Out of these, 396 and 5,836
represented candidate positive NHK and SCC13 growth regula-
tors, respectively, and were signiﬁcantly enriched for Gene
Ontology (GO) terms and gene sets associated with normal cell
growth (Supplementary Fig. 3e and Supplementary Data 4,5).
Genes encoding proteins involved in housekeeping functions,
including 60S and 40S ribosomal proteins, were highly repre-
sented among the hits for both NHKs and SCC13 cells
(Supplementary Fig. 3f and Supplementary Data 3–5). Indeed,
the top 10 gene target hits included multiple ribosomal genes and
genes essential for messenger RNA splicing and protein synthesis
(Fig. 1f,g). As expected, we did not detect any factors known to
directly induce terminal differentiation, such as AP1 transcription
factors23, among the candidate negative regulators of NHK
growth (Supplementary Data 6). We did however detect known
suppressors of NHK proliferation, including E2F5 (ref. 24) and
POU3F1, a transcriptional repressor of TP63 (ref. 25 and Supple-
mentary Data 4).
The SCC13-speciﬁc candidate growth regulators were
signiﬁcantly enriched for GO terms associated with cancer
(Supplementary Fig. 3g,h). AP1 transcription factors and
WNT signalling components, both known to be important for
cSCC growth in vivo21,23,26, were highly represented, as was a
cSCC gene signature compiled from clinically annotated and
transcriptionally proﬁled human samples (Supplementary Fig. 3i
and Supplementary Data 6,7). These ﬁndings are consistent
with the deregulation of multiple signalling pathways and
transcription factors in SCC27 and conﬁrm the power of the
screen to identify regulators of neoplastic growth/viability.
Identiﬁcation of YAP as a positive growth regulator. The top
candidate for positive regulation of NHK growth was YAP1
(Fig. 1f and Supplementary Data 3), encoding the Hippo
signalling effector and transcriptional co-activator YAP28,29. YAP
was also present among the 328 candidate growth regulators
common to both NHKs and SCC13 cells (Supplementary Data 3).
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The YAP paralogue TAZ (WWTR1) was a candidate SCC13 cell-
speciﬁc growth regulator (Supplementary Data 3), consistent with
the observation that TAZ is considerably more abundant in cSCC
cells than NHKs (Supplementary Fig. 4a). Despite compensatory
upregulation of TAZ, YAP knockdown was more effective than
TAZ knockdown in reducing clonal growth of SCC13 cells
(Supplementary Fig. 4b,c), and YAP was highly expressed in
putative cSCC-associated SCs (Supplementary Fig. 4d,e). YAP
acts predominantly through transcription factors of the TEAD
(TEA domain) family30,31. Consistent with this we detected
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TEAD4 among the candidate positive NHK growth regulators
and TEAD3 and TEAD4 among the candidate positive SCC13
cell growth regulators (Supplementary Data 3). Further
underscoring the importance of YAP/TEAD, we found multiple
previously identiﬁed YAP/TAZ/TEAD target genes30,31 among
the candidate positive growth regulators in our screen and in the
cSCC gene signature (Fig. 1h, Supplementary Fig. 3i and
Supplementary Data 7,8). Thus, our screens identiﬁed
YAP/TAZ/TEAD as a key regulator of clonal growth of human
epidermal- and neoplastic (cSCC) SCs in vitro.
To explore the mechanistic networks controlling YAP activity,
we ﬁrst curated the Hippo network interactome by combining
published proteomic data sets32–34 with the list of Hippo pathway
components obtained from Ingenuity. We ﬁltered these 664
Hippo network components for genes that were identiﬁed as
candidate regulators of clonal growth of NHK and SCC13 cells in
the genome-wide shRNA screens (Supplementary Data 9). This
identiﬁed multiple (canonical and non-canonical) Hippo network
components as candidate regulators of clonal SCC13 growth
(Fig. 1i and Supplementary Data 9), but did not provide any
evidence of involvement of canonical Hippo signalling in
regulating YAP activity to promote clonal NHK growth (Fig. 1j
and Supplementary Data 9).
To evaluate canonical Hippo signalling experimentally, we
examined expression of LATS1, one of the two core canonical
Hippo pathway kinases acting immediately upstream of
YAP/TAZ28,29, which phosphorylates YAP on S127. LATS1
was strongly expressed in SCC13 cells but not in NHKs under
growth-promoting culture conditions (Supplementary Fig. 4f).
Consistent with a role of canonical Hippo signalling in
suppressing YAP upon terminal differentiation35, we observed
that when terminally differentiated cells accumulated in
stratifying cultures, the levels of total and activated LATS1
(auto-phosphorylated at S909 (ref. 28)) and pS127 YAP increased
in NHKs, and there was a concomitant downregulation of total
YAP (Supplementary Fig. 4f). This suggested that canonical
Hippo signalling becomes activated during NHK terminal
differentiation to downregulate YAP.
YAP/TAZ are known to be regulated in a non-canonical
manner by WNT signalling36,37. Consistent with WNT signalling
pathway components not being represented among the candidate
positive NHK growth regulators, we found that treatment of
NHKs with the WNT antagonist IWP2 had no effect on YAP
localization and clonogenic growth potential (Supplementary
Fig. 4g,h). Thus our screens provided no evidence for an
involvement of WNT signalling in regulating nuclear
localization of YAP.
WBP2 interacts with YAP to regulate NHK growth. To
examine factors that modulate YAP/TEAD activity in NHKs we
chose 10 candidate genes identiﬁed from the genome-wide screen
that represent non-canonical Hippo network components (Fig. 2a
and Supplementary Data 10). Four of these genes (AMOTL2,
ENY2, DVL1 and NYNRIN) were identiﬁed as negative
growth regulators in the screen and thus represented candidate
YAP suppressors, while the others represented candidate YAP
activators (Fig. 2a). We silenced the expression of each of the 10
candidate genes in NHKs using a customized SMARTpool siRNA
library (Fig. 2b,c). siRNAs targeting YAP1 and TAZ were used as
positive and negative controls, respectively, in addition to
non-targeting control siRNAs. As expected, knockdown of
YAP, but not TAZ, reduced TEAD-mediated transcription, as
measured by reduced transcript levels of the bona ﬁde YAP/TAZ/
TEAD target genes CTGF, CYR61 and BIRC5 (refs 30,31,38,
Fig. 2c and Supplementary Fig. 5a). Although LATS1 was
upregulated during NHK differentiation (Supplementary Fig. 4f),
knockdown of LATS1 or 2, individually or in combination, did
not affect mRNA levels of CTGF and CYR61 (Fig. 2c,
Supplementary Fig. 5a,f,g). Only one siRNA SMARTpool,
targeting WW-binding protein 2 (WBP2), had a robust effect
on YAP transcriptional co-activator functions (Fig. 2c and
Supplementary Fig. 5a). Deconvolution of the WBP2 and YAP
siRNA SMARTpools revealed that each individual siRNA in the
pools was capable of signiﬁcantly downregulating expression of
the respective mRNA and of causing a concomitant decrease in
CYR61 expression (Supplementary Fig. 5b–d). Similar results
were obtained using shRNAs (Supplementary Fig. 5e–g).
WBP2 was shown in Drosophila to cooperate with the YAP
homologue Yorkie to drive tissue growth39, and in human breast
epithelial cells to promote the transforming ability of TAZ40.
However, its functions in mammalian epidermis are unknown.
Using in situ proximity ligation assays (PLA), we conﬁrmed an
interaction of YAP with WBP2 in the nucleus and cytoplasm of
NHKs (Fig. 2d,e and Supplementary Fig. 5i,j). Nuclear abundance
of the YAP/WBP2 complex was higher in SCC13 cells than NHKs
(Fig. 2f). YAP, but not TEADs, could be co-immunoprecipated
with WBP2 (Fig. 2g). However, in the nucleus, both YAP and
WBP2 were in close proximity to TEAD1 (Fig. 2h,i). Knockdown
of WBP2 impaired transcriptional activation of a synthetic TEAD
reporter (8xGTIIC-Lux) to a comparable extent to YAP
knockdown (Fig. 2j), while not affecting the interaction between
YAP and TEADs in the nucleus of NHKs (Supplementary
Fig. 5k–n). Likewise, overexpression of WBP2 in NHKs increased
CYR61 and CTGF expression in a YAP-dependent manner,
but did not affect the expression levels of YAP (Fig. 2k,l).
Figure 1 | Genome-wide screens for growth regulators of normal keratinocytes and SCC13 cells. (a,b) Schematic representation of the RNAi screens
based on relative enrichment/depletion of individual shRNAs over time. Primary human keratinocytes (NHKs, comprising SCs, CP cells, and terminally
differentiated cells) or SCC13 cells are transduced with the shRNA library, and shRNA abundance is analysed 24 h after infection (t¼0). Genes that
regulate clonal growth are then identiﬁed in separate screens, in which infected cells are seeded at clonal density into multilayer ﬂasks containing a
ﬁbroblast feeder layer (3T3-J2) and allowed to grow into colonies over 14 days (t¼ 14). shRNAs targeting essential positive (þ ) growth regulators are
expected to become under-represented at t¼ 14 due to reduced SC growth/survival, while shRNAs targeting negative ( ) growth regulators will become
over-represented at t¼ 14. shRNAs targeting non-essential (n) growth regulators will not change in abundance. (c) After isolation of genomic DNA
(gDNA), individual shRNAs are pre-ampliﬁed and quantiﬁed by sequencing unique 18 bp barcode sequences. (d) Pie chart summaries of the
shRNA-targeted gene hits identiﬁed with our bioinformatics pipeline. Unchanged category: all gene targets whose respective shRNA abundances were not
signiﬁcantly changed (P40.05) at t¼ 14 or for which the average log2-fold change in abundance of respective signiﬁcant shRNAs was lower than the cutoff
of 0.7 or for which the pattern of change in abundances of respective signiﬁcant shRNAs was ambiguous. Enriched and depleted: gene targets whose
respective shRNAs where signiﬁcantly enriched or depleted, respectively, at t¼ 14. (e) Venn diagram depicting total numbers of unique and shared gene
target hits. (f,g) shRNAs for top ten essential regulators of clonal NHK (f) and SCC13 (g) growth are markedly depleted at t¼ 14. (h) Venn diagram
depicting the numbers of gene target hits representing YAP/TAZ/TEAD direct target genes. (i,j) Representation of known Hippo network components
among genes identiﬁed as candidate regulators of SCC13 (i) and NHK (j) growth. Colour scheme identiﬁes genes which were identiﬁed as candidate
positive (green) or negative (red) growth regulators. Colour intensities reﬂect the average log2-fold change in shRNA abundance of the respective gene
targets. Nodes coloured green and grey or red and grey indicate that one or more components were not present in our data set.
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Figure 2 | Identiﬁcation of WBP2 as a YAP co-factor enhancing YAP/TEAD-mediated gene transcription. (a) Candidate non-canonical YAP regulators
(identiﬁed in the screens). Blue: putative YAP activators (shRNAs under-represented at t¼ 14), red: putative YAP suppressors (shRNAs over-represented at
t¼ 14). (b) Screening strategy. (c) Heat map shows mRNA expression levels of YAP/TAZ/TEAD target genes in NHKs transfected with siRNA
SMARTpools targeting YAP regulators identiﬁed in (a) or non-targeting (NTC) siRNA. qRT-PCR data are from ﬁve independent experiments (normalized to
18sRNA). (d) In situ PLA for endogenous YAP/WBP2 interactions in NHKs. Cells with predominantly nuclear (arrows) or cytoplasmic (asterisks)
YAP/WBP2 interactions are shown. Insert, control (primary antibodies omitted). Scale bar, 50mm. (e,f) Quantiﬁcation of YAP/WBP2 PLA signals
(individual data points) in NHKs (e,f) or SCC13 cells (f). One representative experiment with 410,000 cells per condition is shown. Red lines represent
mean. (g) Western blotting of immunoprecipitates and input lysates with antibodies shown. (h) Quantiﬁcation of PLA signals (individual data points) in
NHKs. One representative experiment with 8,000 cells per condition is shown. Red lines represent mean. (i) Representative images (maximum intensity
projections) of in situ PLA detection of endogenous YAP/TEAD1 and WBP2/TEAD1 interactions in NHKs. Inserts, controls (no primary antibodies). Scale
bars, 50mm. (j) Luciferase reporter assay (8xGTIIC) in HEK-293 T cells transfected with the indicated siRNA SMARTpools. Data are from three biological
replicates (independent siRNA tranfections, individual data points and their mean) from one representative experiment. (k) Western blot analysis of NHKs
stably over-expressing two different open reading frames of WBP2 (WBP2-1, WBP2-2) or TurboRFP (tRFP) as control, using antibodies shown. Tubulin was
used as loading control. (l) qRT-PCR analysis of NHKs co-expressing either a YAP-speciﬁc shRNA or a non-targeting control shRNA (shNTC) together with
WBP2 (open reading frame WBP2-1). NHKs expressing shNTC but not over-expressing WBP2 served as control. Data are from three independent
experiments performed with two biological replicates (independent lentiviral infections). Individual data points represent average fold change in mRNA
abundance (normalized to 18sRNA) compared with control (red line) in each experiment. Bars represent the mean. qRT-PCR, quantitative real-time PCR.
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We conclude that WBP2 acts as a co-factor of YAP, enhancing
TEAD-mediated transcription without modulating YAP-TEAD
interaction.
Expression of YAP/WBP2 in NHKs and cSCC cells. It is
well documented that YAP and TAZ are required for normal
epidermal development and hair growth in the mouse30,41,42,
and YAP and TAZ drive pro-tumorigenic signals in mouse
and human cSCC30,43. Nevertheless, there is ambiguity about
YAP/TAZ function: YAP and TAZ are largely dispensible for
homoeostasis of the IFE in adult mouse skin30,42, and in cSCC
both growth-promoting and growth-inhibiting functions have
been documented43,44. This led us to hypothesize that nuclear
YAP/WBP2 abundance (and thus YAP/WBP2/TEAD-mediated
transcriptional activity) might differ in different subpopulations
of NHKs, according to their proliferative potential.
We observed heterogeneous nuclear abundance of both
YAP and WBP2 in basal cells in adult human epidermis
(Fig. 3a). This contrasted with fetal skin, where YAP and
WBP2 were predominantly nuclear in the majority of basal
epidermal cells (Fig. 3b), likely reﬂecting the higher proportion of
proliferative keratinocytes in fetal epidermis45. Similarly, nuclear
YAP and WBP2 were prominent in the basal layer of embryonic
and neonatal mouse IFE (Supplementary Fig. 6a, E17.5 and P0),
but were less abundant in adult IFE (Supplementary Fig. 6a, P21).
During wound healing of adult mouse skin there was a dramatic
increase in nuclear YAP and WBP2 within the epidermis
(Supplementary Fig. 6b). We conclude that abundant nuclear
YAP/WBP2 in human and mouse IFE correlates with a high level
of proliferation.
Consistent with the higher clonogenic growth potential of
cSCC cells compared to NHKs, we found the protein levels of
YAP and WBP2 to be increased in SCC13 and primary cSCC cells
compared with NHKs (Fig. 3c and Supplementary Fig. 4a),
and we also observed increased expression of YAP and WBP2 in a
panel of primary human cSCCs (Fig. 3d,e and Supplementary
Fig. 7). When we fractionated NHK cultures by differential
adhesion to extracellular matrix12, expression of YAP and WBP2
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was highest in the rapidly adhering, SC-enriched, fraction
displaying the highest colony formation efﬁciency (CFE)
(Fig. 3f and Supplementary Fig. 8a). Underscoring these
ﬁndings, we also detected YAP and WBP2 among a set of
genes that are actively transcribed from human epidermal
SC-speciﬁc enhancers (Supplementary Data 11 and 12)46,47.
We observed nuclear YAP/WBP2 in all cells of expanding
NHK colonies that were founded by SCs, but mostly cytoplasmic
YAP/WBP2 in abortive colonies comprising terminal differen-
tiated cells (Fig. 3g and Supplementary Fig. 8b). In large, mature
SC colonies, YAP and WBP2 were found to be nuclear in most
cells at the still actively expanding periphery, but cytoplasmic in
the majority of cells in the colony centre consistent with the
switch to a ‘balanced’ growth mode in response to local contact-
inhibition11 (Fig. 3g and Supplementary Fig. 8b). By constructing
a micro-epidermis on 80 mm diameter micro-patterned circular
adhesive islands48, we could observe that YAP was speciﬁcally
downregulated in terminally differentiating cells (Supplementary
Fig. 8c). Taken together these data suggest that YAP and WBP2
are highly expressed in human epidermal SCs and upregulated in
cSCC, and that nuclear YAP/WBP2 localization indicates an
actively proliferating SC state.
Loss of WBP2 results in reduced epidermal proliferation.
To examine the function of WBP2 in vivo, we examined the
skin of WBP2 knockout mice49. All of the differentiated layers
of the IFE formed normally and there were no obvious hair
follicle abnormalities (Supplementary Fig. 9a,b). Consistent with
YAP/TAZ being upregulated during epidermal development and
wound healing, rather than in steady-state adult epidermis30,41,42,
we observed reduced IFE proliferation in neonatal (P5) but not
adult WBP2 knockout mice (Fig. 4a,b and Supplementary
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Fig. 9c). There was a signiﬁcant reduction in proliferating basal
cells during IFE regeneration of WBP2 knockout compared with
wild-type mice (Fig. 4c,d). This correlated with reduced numbers
of basal cells with nuclear YAP (Fig. 4e,f). These results reveal an
important role of WBP2 in promoting YAP/TEAD-mediated
epidermal proliferation during development and wound healing.
Role of YAP/WBP2 in regulating NHK and cSCC cell growth.
Knockdown of YAP or WBP2 reduced the clonal growth
of NHKs (Fig. 5a). In contrast to YAP knockdown, WBP2
knockdown was not associated with induction of terminal
differentiation (Fig. 5b), but solely with a decrease in proliferation
(Fig. 5c). Knockdown of WBP2, like YAP, also impaired the
clonal growth of SCC13 cells (Fig. 5d). Whereas knockdown
of YAP stimulated terminal differentiation in SCC13 cells,
as indicated by de-novo expression of TGM1 and IVL,
knockdown of WBP2 did not (Fig. 5e,f).
Consistent with YAP/WBP2 acting through TEAD transcrip-
tion factors30,31, knockdown of TEAD proteins expressed in
NHKs also impaired clonal growth (Fig. 5g). Knockdown of
TEAD3 and TEAD4 reduced expression of the YAP/TAZ/TEAD
target genes CTGF, CYR61 and BIRC5 to a similar extent and
did not signiﬁcantly impact on the expression of terminal
differentiation markers. In contrast, knockdown of TEAD1
induced terminal differentiation but only reduced expression of
CTGF (Fig. 5h–j). TEAD proteins were more abundant in SCC13
cells compared with NHKs (Fig. 5k). Together our studies
establish YAP, WBP2 and TEADs as key regulators of
proliferation of human epidermal SCs in vitro and suggest
differential roles in the regulation of terminal differentiation.
The physiological relevance of YAP/WBP2 in human IFE was
veriﬁed by epidermal reconstitution assays in which cells were
seeded onto de-epidermised dermis and cultured at the air–liquid
interface15. After 3 weeks control cells had reconstituted a
morphologically normal IFE with distinct basal, spinous, granular
and corniﬁed layers. In contrast, NHKs expressing YAP or
WBP2-speciﬁc shRNAs were only capable of reconstituting a
hypoplastic epidermis with reduced proliferation (Fig. 6a–c and
Supplementary Fig. 5e–g). Consistent with our in vitro data, there
was premature onset of terminal differentiation in the basal cell
compartment in the case of YAP knockdown epidermis (Fig. 6a).
In contrast, knockdown of LATS1/2 had no effect on epidermal
reconstitution (Fig. 6a–c and Supplementary Fig. 5e–g).
Our data suggest that basal epidermal cells in which YAP has
been silenced will stop proliferating and undergo terminal
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differentiation. To test this, a GFP-IRES-shRNA lentiviral vector
silencing YAP or a control shRNA vector were introduced into
primary human keratinocytes 24 h before organotypic culture15.
After transduction, B25–30% of keratinocytes expressed
each GFP-IRES-shRNA construct (Supplementary Fig. 5h)15.
Three-dimensional whole-mount imaging showed that by 3
weeks there were fewer YAP-targeted than control GFP-positive
clones (Fig. 6d,e). Thus lineage tracing revealed that clonal
expansion of basal cells was signiﬁcantly impaired by YAP
knockdown (Fig. 6d,e).
Regulation of YAP/WBP2 by contact inibition. Having
established a role for YAP/WBP2 in regulating NHK growth,
we next examined the extrinsic signals that regulate YAP. When
single NHKs are seeded on 20mm diameter micro-patterned
islands spreading is restricted and the cells undergo terminal
differentiation. However, on 50 mm diameter islands the cells
spread and do not differentiate50. Consistent with this, on 50 mm
islands the majority of cells had nuclear YAP (Fig. 7a). However,
on 20mm islands most cells had either nuclear YAP or both
cytoplasmic and nuclear YAP (Fig. 7a); thus adhesion to a small
extracellular matrix area was not sufﬁcient to cause efﬁcient
cytoplasmic tranlocation of YAP.
The nuclear exclusion of YAP/WBP2 in the compacted cells in
the centre of mature NHK colonies (Fig. 3g and Supplementary
Fig. 8b) suggested that contact inhibition might play a role in
regulating YAP51,52. Knockdown of LATS1/2 did not prevent
nuclear exclusion of YAP and S127-phosphorylated YAP was
detected in the nucleus of cells at the colony periphery even
though they had high nuclear YAP (Supplementary Fig. 10a,b),
indicating that canonical Hippo signalling was not involved.
Contact inhibition of proliferation involves a gradual compac-
tion of cells that is dependent on cell–cell adhesion and mediated
by mechanical compression through cellular crowding51,52.
Consistent with computational simulations demonstrating that
the rate of adherens junction turnover can be a major
determinant of colony growth53, we found that impairment of
adherens junction homoeostasis by inhibition of Rho GTPase
signalling54 with the Rho kinase (ROCK) inhibitor Y-27632
promoted colony expansion (Fig. 7b,c). Conversely, stabilization
of adherens junctions by inhibition of Src family kinases (SFKs)55,
using the dual Src/Abl kinase inhibitor Dasatinib, blocked colony
expansion (Fig. 7b,c). Neither drug affected total colony forming
efﬁciency (Supplementary Fig. 11a). In the densely packed
Dasatinib-treated colonies YAP and WBP2 were excluded
from the nucleus (Fig. 7d). In contrast, both proteins were
predominantly nuclear in Y-27632-treated colonies, where
compromised adherens junction maintenance, altered F-actin
organization, reduced cell compaction and impaired stratiﬁcation
of terminally differentiated cells were evident (Fig. 7d–f).
Y-27632-treatment increased the total level of YAP without
affecting total and activated LATS1 levels (Fig. 7g), conﬁrming
that canonical Hippo signalling did not control YAP/WBP2
signalling in the context of contact inhibition. Dasatinib
or Y-27632-treatment had no effect on nuclear YAP/WBP2
abundance when single NHKs were conﬁned to micro-patterned
adhesive islands (Supplementary Fig. 11b,c), arguing against a
role of focal adhesion-transduced cytoskeletal tension in
regulating YAP/WBP2 (ref. 56). However, when cell–cell
contact was permitted on non-patterned substrates, Dasatinib
readily induced adherens junctions formation, leading to micro-
colony formation, cell compaction and nuclear YAP/WBP2
exclusion (Supplementary Fig. 11d–g). Y-27632-treatment alone
had no such effect (Supplementary Fig. 11d,e,g), but could
block Dasatinib-induced cell compaction and preserve nuclear
YAP/WBP2 localization (Supplementary Fig. 11g). Thus, cell
compaction, promoted by stabilization of adherens junctions,
controls the subcellular localization of YAP/WBP2 in NHKs.
We next tested if the same mechanism was also operating in
the context of conﬂuent epidermal cell sheets. Using PDMS
substrates that mimic the topography of the epidermal-dermal
interface to recreate the patterned distribution of SCs in adult
human epidermis14, we observed nuclear YAP and WBP2
localization to be restricted to integrin b1-bright SC clusters at
the tips of the topographies (Supplementary Fig. 12a,b). As shown
in Fig. 7h, this highly speciﬁc patterning of YAP activity could be
efﬁciently disrupted by blocking signalling downstream of Rho
GTPase with Y-27632 or the Non-Muscle Myosin II inhibitor
Blebbistatin. Culturing NHKs under low Caþ þ conditions
to prevent adherens junction formation also disrupted the
patterning of nuclear YAP (Supplementary Fig. 12c). Nuclear
YAP was observed in all SCC13 cells (Fig. 7i), consistent with
their inability to form stable adherens junctions41,57 as evidenced
by reduced a-catenin expression (Supplementary Fig. 4a).
We conclude that contact inhibition controls the subcellular
localization of YAP/WBP2 in epidermal sheets.
Discussion
Our genome-wide screens identiﬁed YAP/WBP2/TEAD as
driving clonal expansion of NHK and cSCC SCs in vitro.
While YAP and WBP2 cooperate to promote clonal expansion of
normal and neoplastic human epidermal SCs by driving TEAD-
mediated transcription of proliferation/survival-promoting genes,
YAP supresses the onset of terminal differentiation independently
of WBP2. Consequently, in cSCC cells constitutive nuclear
localization of YAP/WBP2 contributes to their inability to
undergo terminal differentiation.
Although YAP is by default a transcriptional co-activator, it
can also act as a co-repressor in a complex with TEAD
transcription factors and distinct chromatin-modifying pro-
teins58. Our data suggest that YAP might act in cooperation
with TEAD1 to repress terminal differentiation-associated
genes, consistent with the observation that TEAD1 suppresses
involucrin gene transcription59. The co-suppressor functions of
YAP are likely contained within its C-terminus, as overexpression
in mouse epidermis of a constitutively active YAP lacking the
C-terminus does not block terminal differentiation60. The effect
of WBP2 in enhancing the transcriptional co-activator functions
of YAP likely involves the recruitment of factors that
promote chromatin remodelling and productive transcriptional
elongation61. In breast cancer cells, WBP2 cooperates with
b-catenin and YAP/TAZ to drive TCF-mediated gene
transcription downstream of WNT signalling62. Consistent with
ﬁndings from other groups demonstrating that NHKs are only
weakly responsive to WNT signals63, our NHK screen did not
reveal any involvement of WNT signalling in controlling YAP
activity in human epidermal SCs and in driving their clonal
expansion. Thus, different cell types appear to engage YAP/WBP2
via distinct signalling mechanisms for different transcriptional
outputs.
The skin phenotype of WBP2 knockout mice largely
phenocopied that of mice with a conditional, keratinocyte-
speciﬁc knockout of YAP and/or TAZ30,41,42. Knockout of YAP
alone results in reduced proliferation in the embryonic and
neonatal epidermis, while YAP and TAZ have overlapping
functions in promoting proliferation in the regenerating adult
epidermis. However, contrary to the hair loss phenotype reported
for one keratinocyte-speciﬁc YAP/TAZ knockout mouse line42,
WBP2 knockout mice had no obvious hair cycle abnormalities.
Thus, WBP2’s functions in mouse skin in vivo appear to be
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restricted to the IFE, where WBP2 is important for promoting
proliferation of actively cycling epidermal SCs during tissue
development and regeneration.
In mouse epidermis YAP is positively regulated by an integrin-
focal adhesion kinase-SFK signalling axis42, and negatively
regulated by cell–cell contact41,57. Our ﬁnding that nuclear YAP
localization in single cells was unaffected by Dasatinib or Y-27632
treatment argues against an involvement of SFKs and ROCK in
regulating YAP downstream of integrins. Similar observations
were also made by Das et al.64, who found that in the absence of
cell–cell contact, nuclear localization of YAP is independent of
integrin signalling and Myosin II contractility, but is promoted by
the actin cytoskeleton. Our data suggest within epidermal sheets
SFKs and ROCK regulate YAP by modulating the stability of
adherens junctions and the organization and contractility of the
associated actin cytoskeleton and thereby the extent of cell
compaction, which is an essential cue for efﬁcient contact
inhibition51. Supporting our ﬁndings, hyperactivation of Src was
found to drive breast cancer cell invasion by destabilizing
adherens junctions and promoting nuclear localization of
YAP65. Our ﬁndings are also consistent with those of Aragona
et al.51 who showed that mechanical forces transduced and
imposed by the cytoskeleton are the overarching regulators of
YAP/TAZ in multicellular contexts and control their activity
independently of phosphorylation by LATS1/2. Together, our
data suggest an important role for adherens junctions and the
actin cytoskeleton in regulating the epidermal SC compartment
and shed new light on the proliferation-promoting effect of
Y-27632 on primary epidermal cell cultures11,66.
Our ﬁndings provide an explanation for why cSCC cells with
reduced a-catenin levels (and thus impaired adherens junction
formation41,57) fail to exclude YAP/WBP2 from the nucleus at
high cell densities and suggest a role of WBP2 in stabilizing YAP
when cell–cell adhesion is low or absent. We hypothesize that
when YAP is sequestrated on 14-3-3 proteins and a-catenin upon
contact inhibition41, it is protected from phosphorylation-
induced proteosomal degradation29, but in the absence of stable
cell–cell adhesion, such as is found in the regenerating epidermis
or in cSCC, cells rely on WBP2 to stabilize YAP.
We conclude that YAP, in cooperation with WBP2, is a key
driver of proliferation of actively cycling epidermal SCs in vitro
and in vivo. Since YAP functions are preserved in other stratiﬁed
epithelia38,67,68, our ﬁndings may help to elucidate the molecular
regulation of proliferative heterogeneity in these tissues.
Methods
Mice. All animal experiments were subject to local ethical approval and performed
under the terms of a UK government Home Ofﬁce license. Wbp2tm2a(EUCOMM)Wtsi
mice (outbred on a C57BL6/CBA background) were provided by Karen P. Steel49.
Homozygous mutant mice are referred to as Wbp2 / . Wild-type
(Wbp2þ /þ ) and heterozygous (Wbp2þ /-) mice were used as controls and showed
no apparent phenotype in skin49 (Supplementary Fig. 9). Animals were genotyped
using standard procedures, and with the recommended set of primers49. In the
developmental analysis time course both male and female mice were analysed,
while for the wound healing experiment only 8-weeks-old adult female mice were
used. Before wounding, back skin hair was clipped and mice were anaesthetized
using isoﬂuorane (CP-Pharma) and injected subcutaneously with the analgesic
Vetergesic (diluted 1:20 in sterile PBS; 100 ml per 20 g body weight; Ceva Animal
Health). A 5mm diameter biopsy punch (Stiefel) was used to introduce a full-
thickness wound in the central back skin, and wounds were excised at the indicated
time points and embedded in optimal cutting temperature compound (OCT). All
tested animals were included; no statistical method was used to predetermine
sample size; no randomization or blinding was used.
Human tissues. All human tissues were collected after informed consent and in
compliance with either UK national regulations (UK Human Tissue Act (2004)) or
German national regulations (German Medical Council). Human embryonic and
fetal tissues were obtained with appropriate ethical approval from the UK Human
Developmental Biology Resource (www.hdbr.org).
Pharmacological inhibitors. The ROCK inhibitor Y27632 was obtained from
Enzo (ALX-270-333) and the Myosin II inhibitor Blebbistatin from Cambridge
Bioscience (CAY13165). PP2 and IWP2 were from Tocris (#3533, #1407) and
Dasatinib was from Cell Signalling Technologies (#9052). Y27632 was dissolved in
sterile Milli-Q water; all other inhibitors were dissolved in sterile DMSO.
Microfabrications. CYTOOchips Arena micro-patterned glass slides and
custom-manufactured composite micro-patterned glass slides containing arrays of
20 and 50mm diameter circular islands were purchased from CYTOO (Grenoble,
France); the custom-designed template masks to print new slides are available upon
request (Custom_CC20_Q13-24-38). PDMS elastomer substrates mimicking the
topography of the epidermal-dermal interface were fabricated as described14.
Topography S1 was used for experiments14.
Cell culture. Stock cultures of primary normal human keratinocytes (NHKs, strain
km) were obtained from surgically discarded foreskin. SCC13 cells are an estab-
lished cutaneous SCC cell line isolated from a cutaneous SCC of facial epidermis10,
and were obtained from Dr. James Rheinwald (Department of Dermatology,
Harvard Skin Research Centre, USA), not authenticated. NHK and SCC13 cells
were used in all experiments at passages 2–5. SCC-NR cells were isolated by
Dr Nicholas Rabey at Addenbrooke’s Hospital (Cambridge, UK) from a portion of
a surgically excised cutaneous SCC from the back of the hand of an elderly male
patient, and were used in all experiments at passages 1 or 2. HEK-293 T cells were
purchased from ATCC (CRL-3216). 3T3-J2 ﬁbroblasts were originally obtained
from Dr James Rheinwald (Department of Dermatology, Harvard Skin Research
Centre, USA), not authenticated. All cell stocks were routinely tested for
mycoplasma contamination and were negative. None of the cell lines used in this
study is present in the database of commonly misidentiﬁed cell lines. NHKs and
cutaneous SCC cells were cultured in complete FAD medium, containing 1 part
Ham’s F12, 3 parts Dulbecco’s modiﬁed eagle medium (DMEM), 10 4M adenine,
10% (v/v) FBS, 0.5 mgml 1 hydrocortisone, 5 mgml 1 insulin, 10 10M cholera
toxin and 10 ngml 1 EGF, on mitotically inactivated 3T3-J2 cells as described
previously9,12. HEK-293T cells were cultured in high-glucose DMEM (Sigma-
Aldrich) supplemented with 100 IUml 1 penicillin, 100 mgml 1 streptomycin
and 10% (v/v) FBS (Life Technologies). 3T3-J2 cells were cultured in high-glucose
DMEM (Sigma-Aldrich) supplemented with 100 IUml 1 penicillin, 100 mgml 1
streptomycin and 10% (v/v) adult BS (Life Technologies). 3T3-J2 cells were
mitotically inactivated either by irradiation or by mitomycin C-treatment (3 h,
4 mgml 1 ﬁnal concentration, Sigma-Aldrich). For experiments shown in
Supplementary Fig. 11d–g, cells were seeded into cell culture multi-well plates
(Falcon) or onto glass coverslips, coated with rat-tail collagen type I (20 mgml 1 in
PBS, BD Biosciences), and grown in the absence of feeder cells in keratinocyte
serum-free medium (KSFM) containing 30 mgml 1 bovine pituitary extract and
0.2 ngml 1 EGF (Thermo Fisher Scientiﬁc) for 24 h before treatment. For
induction of terminal differentiation, cells were seeded at a density of 3.5 104 cells
per cm2 into cell culture dishes (Falcon) coated with rat-tail collagen type I
(20 mgml 1 in PBS, BD Biosciences), grown to conﬂuence in KSFM and then
switched to complete FAD medium. For experiments using glass microchips
containing micro-patterned arrays of 20 and/or 50 mm diameter circular islands,
pre-conﬂuent NHKs were gently disaggregated in trypsin/EDTA following removal
of the feeder layer, ﬁltered twice through a 40 mm cell strainer (Falcon) and re-
seeded onto the substrates at a density of 1 104 cells cm 2 in KSFM. Cells were
allowed to adhere for 1 h and the substrates were then rinsed ﬁve times with fresh
medium to remove non-attached cells. To generate micro-patterned arrays of
micro-epidermis, NHKs or SCC13 cells were seeded onto CYTOOchips Arena at a
density of 2 105 cells per cm2 in complete FAD medium. After removing cells not
adhering within 1 h by extensive washing, the remaining adherent cells were then
cultured for 48 h. For the small-scale siRNA screen, 1 105 siRNA SMARTpool-
transfected NHKs were seeded per well into 24-well cell culture plates (Falcon)
coated with rat-tail collagen type I (20mgml 1 in PBS, BD Biosciences), and
cultured for 48 h in complete FAD medium. NHKs were seeded onto rat-tail
collagen type I (20mgml 1 in PBS, BD Biosciences)-coated PDMS substrates in
complete FAD medium at a density of 5 105 cells per cm2. After 45min,
substrates were rinsed gently to remove
non-adherent cells and transferred to 12-well cell culture plates (Falcon) containing
a 3T3-J2 feeder layer14.
Cell fractionation by differential adhesion. Cell fractions enriched for human
epidermal SCs, CP/transient amplifying cells and terminally differentiated
cells were prepared as described12, using human placenta collagen type IV
(Sigma-Aldrich). For ﬂuorescence microscopy of colonies, feeder cells were added
at low density after SCs or CP/transit amplifying cells had been captured, and the
cells were cultured for 10 days.
Enrichment of cutaneous SCC-associated stem cells. Enrichment of SCs
from SCC13 cell cultures was achieved by spheroid growth-promoting culture on
ultra-low adherence plates (Corning Costar) as described69.
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Clonal growth assays. 100 or 400–800 live (Trypan Blue-negative) NHK or
SCC13 cells, respectively, were seeded per condition into duplicate or triplicate
wells (containing a 3T3-J2 feeder layer) of a six-well dish (Falcon). After 12 days,
feeder cells were completely removed by rinsing with PBS and colonies were either
ﬁxed in 4% (w/v) paraformaldehyde for 10min and then stained with 1% Rho-
danile Blue (1:1 mixture of Rhodamine B and Nile Blue A (Acros Organics))12, or
simultaneously ﬁxed and stained with Crystal Violet solution (0.4% (w/v) crystal
violet, 20% (v/v) methanol). Colonies were imaged and counted using an
automated cell colony counter (Gelcount, Oxford Optronix, UK), and CFE was
calculated as the average percentage of seeded cells that formed colonies. Colony
area was measured using the Fiji image processing software package and the
‘Analyse Particles’ tools, with a minimum particle size of 0.01mm2.
Epidermal reconstitution assays. These were performed as described pre-
viously15. In brief, NHKs cultured on feeder cells to B70% conﬂuence were
disaggregated in trypsin/EDTA and cells (5 105) were seeded into six-well cell
culture plates (Falcon) coated with rat-tail collagen type I (20 mgml 1 in PBS, BD
Biosciences), and cultured for 24 h in KSFM medium. NHKs were then infected
with MISSION lentiviral particles (Sigma-Aldrich; the sequences of the shRNAs
can be found in Supplementary Table 1) at an multiplicity of infection (MOI) of
two in the presence of 5 mgml 1 polybrene (Sigma-Aldrich). Medium was
replaced after 24 h and shRNA-expressing cells were selected for 72 h using
puromycin (2 mgml 1, Sigma-Aldrich). At 96 h after infection, cells were collected
and seeded (5 105) on irradiated de-epidermized human dermis in six-well
Transwell plates with feeder cells and cultured at the air–liquid interface for three
weeks15. For analysis of clonal expansion during epidermal reconstitution, we used
pGIPZ-based lentiviral vectors (GE Dharmacon) expressing miR30 embedded
shRNAs silencing YAP (Clone V3LHS_306099) or a non-targeting control shRNA
(#RHS4346). GFP was expressed from the same promoter through an IRES. Three-
dimensional imaging of reconstituted epidermis was performed on a two-photon
Leica confocal microscope. Quantiﬁcation of the unprocessed data was performed
using Volocity software.
WBP2 overexpression. Pre-conﬂuent NHK cultures were disaggregated and cells
(2 105) were seeded into six-well cell culture plates (Falcon) coated with rat-tail
collagen type I (20 mgml 1 in PBS, BD Biosciences), and cultured for 24 h in
KSFM medium. NHKs were then infected with Precision LentiORF (GE Dhar-
macon) lentiviral particles co-expressing different WBP2 ORFs (OHS5901,
OHS5902) or TurboRFP and nuclear localized TurboGFP as ﬂuorescent reporter at
an MOI of 5 in the presence of 5 mgml 1 polybrene (Sigma-Aldrich). Medium was
replaced after 24 h and cells were harvested after 72 h. Quantiﬁcation of TurboGFP
expression revealed transduction efﬁciencies of B70%.
Genome-wide pooled shRNA screens. Details can be found in Supplementary
Methods.
RNA extraction and real-time qPCR. Total RNA was isolated from cultured cells
using the RNeasy kit (Qiagen). Complementary DNA was generated using the
QuantiTect Reverse Transcription kit (Qiagen). Quantitative PCR (qPCR) analysis
of cDNA was performed using qPCR primers (published or designed with
Primer3) and Fast SYBR green Master Mix (Life Technologies). RT-qPCR reactions
were run on CFX384 Real-Time System (Bio-Rad). 18S rRNA was used as a
housekeeping gene for normalization. Please refer to Supplementary Table 2 for
qPCR oligos sequences.
Plasmid DNA transfection. HEK-293 T cells were transfected with plasmid DNAs
in six-well dishes (Falcon) using jetPRIME reagent (Polyplus Transfection)
following the manufacturer’s instructions.
siRNA transfection. siRNA nucleofection was performed with the Amaxa 96-well
shuttle system (Lonza). Pre-conﬂuent NHK cultures were disaggregated and
resuspended in cell line buffer SF (Lonza). For each 20 ml transfection (program
FF-113) reaction, 2 105 cells were mixed with 1 mM siRNA duplexes as described
previously15. Transfected cells were allowed to recover at ambient temperature for
10min and were subsequently re-plated into rat-tail type I collagen (20 mgml 1 in
PBS, BD Biosciences)-coated cell culture well plates (Falcon) and, unless stated
otherwise, grown in KSFM medium for 24 h before being used for downstream
assays. SMARTpool ON-TARGET plus siRNAs (GE Dharmacon) were used for
gene knockdown. Each SMARTpool was a mix of four sets of RNAi oligos (the
sequences of siRNA oligos can be found in Supplementary Table 3). Non-targeting
control siRNAs were from Ambion (AM4611 and AM4637). SCC13 cells (5 105)
were reverse transfected with siRNAs (25 pmol) in six-well dishes (Falcon) using
Lipofectamine RNAiMAX reagent in combination with Opti-MEM medium
(Life Technologies) according to the manufacturer’s instructions.
Chemiluminescent reporter gene assays. Reporter gene assays were performed
using the Dual-Light System (Applied Biosystems). B50% conﬂuent HEK-293T
were transfected with SMARTpool siRNAs (12 pmoles cm 2) in six-well cell
culture plates (Falcon) using jetPRIME reagent (Polyplus Transfection) following
the manufacturer’s instructions. Twenty-four hours after siRNA transfection,
TEAD reporter plasmid (8xGTIIC–LUX56; a gift from Stefano Piccolo, University
of Padova, Italy; Addgene #34615) was transfected into the cells (200 ng cm 2)
together with b-galactosidase plasmid (pEF-1a-LacZ 200 ng cm 2, Addgene
#17430; kindly provided by Dr Shukry Habib, CSCRM, King’s College London,
UK) to normalize for transfection efﬁciency, using jetPRIME reagent (Polyplus
Transfection) following the manufacturer’s instructions. At 24 h post-plasmid
transfection, cells were trypsinized and re-plated (1 104 cells) in triplicates into a
96-well plate, and allowed to grow for a further 24 h. Relative luciferase units were
measured on a Glo-Max-Multiþ Multimode Reader (Promega) and normalized
against b-galactosidase activity.
Immunoﬂuorescence microscopy of cultured cells. Cultured cells grown on
CYTOO microchips or on glass coverslips (coated with rat-tail type I collagen
(20 mgml 1 in PBS, BD Biosciences)) were ﬁxed in 4% (w/v) paraformaldehyde
(Sigma) for 10min and permeabilized with 0.2% (v/v) Triton X-100 for 5min at
ambient temperature. NHK colonies grown in the presence of a 3T3-J2 feeder layer
were ﬁxed in 4% (w/v) paraformaldehyde (Sigma) for 45min and permeabilized
with 0.5% (v/v) Triton X-100 for 45min at ambient temperature. Conﬂuent NHK
sheets grown on PDMS substrates with patterned topographies were processed for
immunoﬂuorescence microscopy as previously described14. Samples were blocked
for 1 h in 10% (v/v) FBS plus 0.25% (v/v) ﬁsh skin gelatin (Sigma-Aldrich) in 1
PBS (blocking buffer), and incubated with primary antibodies (diluted in blocking
buffer) in a humid chamber overnight at 4 C. After washing with PBS, samples
were incubated with Alexa Fluor-conjugated secondary antibodies for 2 h at room
temperature. Primary antibodies are listed in Supplementary Data 13. Rhodamine–
phalloidin (Thermo Fisher Scientiﬁc) was included in the secondary antibody
solution where indicated. Fixed and stained coverslips were mounted on glass slides
with ProLong Gold anti-fade reagent with DAPI (Thermo Fisher Scientiﬁc).
Confocal images were acquired with a Nikon A1plus or A1r point scanning
confocal ﬂuorescence microscope equipped with Plan Fluor ELWD 20x Ph2 ADL-,
S Plan Fluor ELWD 20x Ph1 ADL-, Plan Apo VC 20x DIC N2-, Plan Apo 40x DIC
M N2-, or Plan Fluor ELWD 40x Ph2 ADL objectives (Nikon) and controlled by
NIS elements C software. Digital images were processed using NIS elements
Advanced Research and Adobe software packages.
In situ proximity ligation assays. In situ PLA was performed with DuoLink In
Situ Reagents from Olink Bioscience (Sigma-Aldrich). NHK cells were seeded onto
glass coverslips coated with rat-tail type I collagen (20mgml 1 in PBS, BD Bios-
ciences), grown for 24 h in complete FAD medium, and ﬁxed in 4% (w/v) paraf-
ormaldehyde (Sigma) for 10min at room temperature. PLAs were performed as
indicated by the provider’s protocol, after an overnight incubation with primary
antibodies following the immunoﬂuorescence protocol described above. Primary
antibodies are listed in Supplementary Data 13.
Immunoﬂuorescence microscopy of tissue sections. Human and mouse tissue
samples were embedded in OCT compound and 12 mm sections (mouse and
human skin) or 10mm sections (reconstituted human skin) were cut on a cryostat
and ﬁxed in 4% (v/v) paraformaldehyde (Sigma). Tissues obtained from skin
biopsies of cancer patients or healthy donors were ﬁxed in 4% (w/v)
paraformaldehyde (Sigma) for 24 h and embedded in parafﬁn after dehydration.
5 mm thick sections were deparafﬁnised, subjected to antigen retrieval using citrate
buffer, and permeabilized with 0.5% (v/v) Triton X100 in PBS. Tissue sections were
incubated in blocking buffer (3% (v/v) BSA, 5% (v/v) FBS, 0.25% (v/v) ﬁsh skin
gelatin, in 1 PBS) for 20min before staining with primary antibodies overnight
at 4 C. In some cases, primary antibodies had been directly conjugated with Alexa
ﬂuorophores using Molecular Probes Antibody Labelling Kits (Thermo Fisher
Scientiﬁc). Otherwise, Alexa Fluor-conjugated secondary antibodies were used.
Primary antibodies are listed in Supplementary Data 13. DAPI was used to label
nuclei. Confocal images were acquired with a Nikon A1plus point scanning con-
focal ﬂuorescence microscope equipped with a CFI Plan Apo l  40 objective
(Nikon) and controlled by NIS elements C software. Digital images (single optical
sections) were processed using NIS elements Advanced Research and Adobe
software packages.
High content imaging analysis. Cells were processed for immunoﬂuorescence
microscopy as described above. Automated image acquisition was performed on an
Operetta high content imaging system (Perkin Elmer). For image scanning, 25–30
ﬁelds (quantiﬁcation of nuclear YAP abundance, Supplementary Figs 5n and
11c,d), 60–80 ﬁelds (quantiﬁcation of subcellular YAP localization, Fig. 7a), or
150–200 ﬁelds (quantiﬁcation of PLA signals, Fig. 2e,f,h and Supplementary
Figs 5m and 11f) without ﬂuorescence artifacts were selected for each glass cov-
erslip or CYTOO chip, and z-stack images (z-dimension 1 mm) were acquired using
 10 (quantiﬁcation of nuclear YAP abundance, Supplementary Figs 5n and 11c,d;
quantiﬁcation of subcellular YAP localization, Fig. 7a) and  20 (quantiﬁcation of
PLA signals, Fig. 2e,f,h and Supplementary Figs. 5m and 11f) long WD objectives
via DAPI (20ms exposure), Alexa-488 (200ms exposure) and Alexa-594 (200ms
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exposure) channels. Images were analysed using custom algorithms in the
Harmony high content analysis software package (Perkin-Elmer). For all image
analyses, cells were initially deﬁned using the DAPI channel, then the cytoplasm
was segmented using one of the Alexa channels. Nuclear abundance was calculated
as the ratio of median ﬂuorescence intensity in the nucleus to median ﬂuorescence
intensity in the cytoplasm. The complete Harmony image analysis sequences can
be provided upon request.
Semi-quantitative analysis of immunoﬂuorescence intensities. Immuno-
ﬂuorescence intensities in sections of normal human skin and from cSCCs were
scored by one dermatologist (S.Q.) and one biologist (B.L.), who was blinded to
clinical outcome, using the H-score method70. Cellular YAP and WBP2
immunoﬂuorescence intensities were ﬁrst scored as 0, 1, 2 or 3 corresponding to
the presence of no signal in the basal layer signal in normal tissue, signal intensity
similar to basal layer signal in normal tissue, signal intensity higher than basal layer
signal in normal tissue, and signal intensity much higher relative to basal layer
signal in normal tissue. The average percentage of positive cells was then calculated
and the following formula applied: H-score¼ (% of cells stained at intensity
category 1 1)þ (% of cells stained at intensity category 2 2)þ (% of cells
stained at intensity category 3 3). An H-score between 0 and 300 was obtained
where 300 was equal to 100% of cells stained strongly (3þ ).
Bioinformatics analyses. Details can be found in Supplementary Methods.
Western blotting. Cells were lysed on ice for 30min in 1 RIPA buffer
(Cell Signalling Technology) supplemented with PhosSTOP Phosphatase Inhibitor
and cOmplete EDTA-free Protease Inhibitor Cocktails (Roche), and RIPA-soluble
and -insoluble proteins were separated via centrifugation (16,000 g for 20min at
4 C). Total protein amount was quantiﬁed in RIPA extracts using the BCA kit
(Pierce). Equivalent quantities of RIPA-solubilized proteins were resolved by
SDS-PAGE in 4–20% Criterion TGX Stain-Free Precast Gels and transferred to
Immun-Blot Low Fluorescence polyvinylidene diﬂuoride membranes (Bio-Rad
Laboratories) using the Trans-Blot Turbo transfer system (Bio-Rad Laboratories).
Protein transfer and equal protein loading were conﬁrmed by enhanced tryptophan
ﬂuorescence imaging of polyvinylidene diﬂuoride membranes (Bio-Rad
Laboratories). Membranes were blocked with either 5% (w/v) non-fat milk or
5% (w/v) BSA in PBS supplemented with 0.05% (v/v) Tween-20 (PBS-T) and
then probed with the indicated antibodies diluted in blocking buffer. Primary
antibody-probed blots were visualized with appropriate horseradish peroxidase-
coupled secondary antibodies (Jackson ImmmunoResearch) using enhanced
chemiluminescence (Clarity Western ECL, Bio-Rad Laboratories) according to the
manufacturer’s instructions. Protein bands were detected using a ChemiDoc Touch
Imaging System (Bio-Rad Laboratories). Processing of western blot images was
done by Image Lab software (Bio-Rad Laboratories). For quantiﬁcations of band
intensities, exposures within the dynamic range were chosen. Images of uncropped
blots are shown in Supplementary Fig. 13.
Immunoprecipitation. For co-immunoprecipitations of endogenous protein
complexes, cells were lysed on ice for 45min in 50mM Tris-HCl (pH 8.0), 150mM
NaCl, 10% (v/v) glycerol, 0.5% (v/v) Triton X-100, 1mM MgCl2 and protease and
phosphatase inhibitors. Equal quantities of solubilized proteins (500 mgml 1)
were incubated with anti-YAP- or anti-WBP2 antibodies overnight at 4 C.
Immunoprecipitates were captured on protein G-agarose columns (Active Motif),
washed three times with NET buffer (50mM Tris-HCl (pH 7.5), 150mM NaCl,
1mM EDTA, 0.25% (v/v) gelatine and 0.1% (v/v) Nonidet P-40) and analysed by
immunoblotting.
Reproducibility of experiments. For genome-wide pooled shRNA screens,
two independent experiments were performed. For the small-scale siRNA screen,
ﬁve independent experiments were performed with two biological replicates
(independent siRNA transfections). For all other experiments involving
pharmacological inhibitor-, siRNA- or shRNA treatments, three to ﬁve
independent experiments were performed with two biological replicates
(independent siRNA or shRNA transfections or drug treatments) per condition.
For epidermal reconstitution assays, one experiment was performed with
three biological replicates (independent lentivirus infections and epidermal
reconstitutions). For quantiﬁcation of expanding GFPþ clones in reconstituted
human epidermis, three independent experiments were performed with six
technical replicates. For clonal growth assays two to three independent experiments
were performed with two to three technical replicates per condition. Western blots,
PLA assays, and high content imaging-based quantiﬁcations of immunostainings
were performed at least twice with similar results. For luciferase reporter assays,
each experiment contained three biological replicates (independent siRNA
transfections) and was repeated twice independently with similar results. For
immunostainings, representative images from one out of three experiments are
shown. For immunoprecipitations two independent experiments were performed
with similar results.
Statistics and graph generation. No statistical method was used to predetermine
sample size. Data sets with sufﬁcient n numbers were ﬁrst analysed using the
D’Agnostino & Pearson Omnibus normality test. In cases where the data were not
found to be normally distributed, they was subsequently analysed using appropriate
non-parametric tests (speciﬁed in ﬁgure legends), provided that the variance was
comparable between the groups analysed. In cases of small data sets (no3), the
individual data points are displayed in the graphs. All graphs were generated using
GraphPad Prism 6 and 7.
Antibodies. Primary and secondary antibodies are listed in Supplementary
Data 13.
Data availability. The authors declare that all data supporting the ﬁndings of this
study are available within the paper and its Supplementary information ﬁles. Raw
Illumina sequencing data from the genome-wide pooled shRNA screens are
deposited in the Gene Expression Omnibus (GEO) under the accession number
GSE79560.
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